{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "regularMarketChangePercent": 1.9801947, "regularMarketPrice": 0.0309, "exchange": "PNK", "shortName": "ELITE PHARMACEUTICALS INC", "longName": "Elite Pharmaceuticals, Inc.", "messageBoardId": "finmb_528102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 0.03, "fiftyDayAverage": 0.03, "fiftyDayAverageChange": 0.00090000033, "fiftyDayAverageChangePercent": 0.030000012, "twoHundredDayAverage": 0.0342, "twoHundredDayAverageChange": -0.0033000018, "twoHundredDayAverageChangePercent": -0.09649128, "marketCap": 32498456, "priceToBook": 1.03, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1581386400, "earningsTimestampStart": 1596844800, "earningsTimestampEnd": 1597190400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.0, "sharesOutstanding": 1013920000, "firstTradeDateMilliseconds": 951402600000, "priceHint": 4, "regularMarketChange": 0.000599999, "regularMarketTime": 1684180279, "regularMarketDayHigh": 0.031, "regularMarketDayRange": "0.0303 - 0.031", "regularMarketDayLow": 0.0303, "regularMarketVolume": 92759, "regularMarketPreviousClose": 0.0303, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.0303, "averageDailyVolume3Month": 306773, "averageDailyVolume10Day": 240500, "fiftyTwoWeekLowChange": 0.00090000033, "fiftyTwoWeekLowChangePercent": 0.030000012, "fiftyTwoWeekRange": "0.03 - 0.05", "fiftyTwoWeekHighChange": -0.019100001, "fiftyTwoWeekHighChangePercent": -0.38200003, "fiftyTwoWeekLow": 0.03, "fiftyTwoWeekHigh": 0.05, "marketState": "PRE", "displayName": "Elite Pharmaceuticals", "symbol": "ELTP"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "165 Ludlow Avenue", "city": "Northvale", "state": "NJ", "zip": "07647", "country": "United States", "phone": "201 750 2646", "fax": "201 750 2755", "website": "https://www.elitepharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the brand Loxapine; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Nasrat  Hakim", "age": 61, "title": "Chairman, CEO & Pres", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 1078000, "fmt": "1.08M", "longFmt": "1,078,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Douglas  Plassche", "age": 58, "title": "Exec. VP of Operations", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 661546, "fmt": "661.55k", "longFmt": "661,546"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Pellegrino", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Dianne  Will", "title": "VP of Investor Relations & Corp. Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. George Kenneth Smith J.D., M.B.A., Ph.D.", "title": "VP of Legal", "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kirko  Kirkov", "title": "Chief Commercial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}